Cargando…
Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570440/ https://www.ncbi.nlm.nih.gov/pubmed/34749010 http://dx.doi.org/10.1016/j.ijid.2021.11.002 |
| _version_ | 1784594840126750720 |
|---|---|
| author | Baos, Elvira Delgado-Iribarren, Alberto O´Connor, Silvia Bardón, Ignacio Alvaréz, Mar Rodríguez-Avial, Iciar Culebras, Esther |
| author_facet | Baos, Elvira Delgado-Iribarren, Alberto O´Connor, Silvia Bardón, Ignacio Alvaréz, Mar Rodríguez-Avial, Iciar Culebras, Esther |
| author_sort | Baos, Elvira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8570440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85704402021-11-08 Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection Baos, Elvira Delgado-Iribarren, Alberto O´Connor, Silvia Bardón, Ignacio Alvaréz, Mar Rodríguez-Avial, Iciar Culebras, Esther Int J Infect Dis Short Communication The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-01 2021-11-05 /pmc/articles/PMC8570440/ /pubmed/34749010 http://dx.doi.org/10.1016/j.ijid.2021.11.002 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Short Communication Baos, Elvira Delgado-Iribarren, Alberto O´Connor, Silvia Bardón, Ignacio Alvaréz, Mar Rodríguez-Avial, Iciar Culebras, Esther Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title | Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title_full | Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title_fullStr | Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title_full_unstemmed | Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title_short | Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection |
| title_sort | negative effect of the second dose of the bnt162b2 vaccine in a significant percentage of individuals with previous covid infection |
| topic | Short Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570440/ https://www.ncbi.nlm.nih.gov/pubmed/34749010 http://dx.doi.org/10.1016/j.ijid.2021.11.002 |
| work_keys_str_mv | AT baoselvira negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT delgadoiribarrenalberto negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT oconnorsilvia negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT bardonignacio negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT alvarezmar negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT rodriguezavialiciar negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection AT culebrasesther negativeeffectoftheseconddoseofthebnt162b2vaccineinasignificantpercentageofindividualswithpreviouscovidinfection |